Details

Autor(en) / Beteiligte

• JANECKE, Andreas R
• HIRST-STADLMANN, Almut
• GÜNTHER, Barbara
• UTERMANN, Barbara
• MÜLLER, Thomas
• LÖFFLER, Judith
• UTERMANN, Gerd
• NEKAHM-HEIS, Doris

Titel

Progressive hearing loss, and recurrent sudden sensorineural hearing loss associated with GJB2 mutations -phenotypic spectrum and frequencies of GJB2 mutations in Austria

Ist Teil von

• Human genetics, 2002-08, Vol.111 (2), p.145-153

Ort / Verlag

Heidelberg: Springer

Erscheinungsjahr

2002

Quelle

MEDLINE

Beschreibungen/Notizen

• Mutations of GJB2 (encoding connexin 26) are the most common cause of hearing loss (HL) in different populations, and a broad spectrum of GJB2 mutations has been identified. We screened 204 consecutive patients with non-syndromic sensorineural hearing loss for GJB2 mutations. Causative GJB2mutations were identified in 31 (15.2%) patients, and two common mutations, c.35delG and L90P (c.269T>C), accounted for 72.1% and 9.8% of GJB2 disease alleles. In four additional patients (2.0%) only one recessive GJB2 mutation was identified, making genetic counselling difficult. No genotype-phenotype correlation was established. We found, however, that homozygotes for truncating mutations were more likely to have a more severe degree of HL compared with other genotypes. Moreover, we showed by co-segregation studies that L90P is a GJB2 disease allele, and that compound heterozygotes for L90P and any recessive mutation share a mild to moderate phenotype. GJB2-associated HL was linked with progressive HL or with recurrent sudden sensorineural hearing loss (SSNHL) in three of 15 cases being analysed retrospectively. We extended the phenotypic spectrum of GJB2-related disease and recommend GJB2 mutation screening also in cases of progressive HL, and recurrent SSNHL. In addition, a carrier frequency of 1/110 (0.9%) for the most common Caucasian mutation in this gene, c.35delG, was determined in 1,212 blood donors from West-Austria, supporting the prevailing hypothesis of a Mediterranean founder mutation. Based on population and patient data, an overall GJB2 mutation carrier frequency of 1.3% was estimated for West-Austria.